AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2020

Oct 7, 2020

29745_dirs_2020-10-07_4f9e3331-da9a-4b4f-bc9f-8d61232ffbba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-10-04

Reporting Person: Yuffa Ilya (SVP and Pres, Lilly Bio-Meds)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6813	Direct

Footnotes

F1: This amendment is being filed solely to gain access to the filing system in order to attach the power of attorney authorization. This line item is being re-reported for this purpose.